Flat Medical Partners with Mercury Medical for US Distribution of EpiFaith Smart Syringe

Strategic Partnership Brings Breakthrough Epidural Safety Technology to US Anesthesia Market

AUSTIN, Texas, June 16, 2025 /PRNewswire/ -- Flat Medical, a pioneering medtech company specializing in innovative safety solutions for anesthesia and pain medicine, today announced it has signed a dealership agreement with Mercury Medical for the distribution of the EpiFaith Smart Syringe in the US anesthesia market.

The EpiFaith Smart Syringe transforms traditional epidural procedures by converting the tactile loss-of-resistance technique into an objective visual signal. This breakthrough technology enables anesthesia providers to identify the epidural space more accurately while keeping both hands free for optimal needle control, helping reduce the risk of accidental dural puncture and related complications.

"This partnership with Mercury Medical represents a significant step in expanding our reach to healthcare providers across America," said Mark Rabe, Director of Sales and Distribution at Flat Medical. "Mercury Medical's comprehensive sales team and deep market expertise provide us with the specialized resources to penetrate hospitals nationwide and deliver EpiFaith technology to clinicians who need it most."

Mercury Medical, with over 60 years of experience in clinical equipment markets, specializes in airway management and respiratory equipment. The company maintains an extensive distribution network throughout the healthcare industry.

"We are excited to partner with Flat Medical to bring this groundbreaking epidural safety technology to our customers," said John Gargaro, M.D., CEO and President of Mercury Medical. "The EpiFaith Smart Syringe aligns perfectly with our mission to deliver clinically differentiated critical care technology that saves lives."

The EpiFaith technology has received significant industry recognition, including an Innovative Technology contract from Vizient, Inc. and a Technology Breakthrough Designation from Premier, Inc. The product has been successfully used in thousands of clinical epidural placements globally, with multiple studies in obstetric anesthesia, regional anesthesia and interventional pain management demonstrating superior safety and reliability compared to conventional techniques.

The partnership leverages Mercury Medical's comprehensive sales force and extensive US distribution network with Flat Medical's proven safety technology to accelerate market penetration and reach hospitals nationwide, addressing growing demand for enhanced epidural procedure safety in labor analgesia, surgical anesthesia, and chronic pain management.

About Flat Medical
Founded in 2015, Flat Medical develops innovative safety solutions for anesthesia, pain management, and critical care. The company's comprehensive product portfolio includes the EpiFaith syringe for epidural procedures, EpiFaith CV for central venous catheterization, and IQ-Tip for enhanced procedural precision. Flat Medical's flagship EpiFaith products are used in renowned hospitals worldwide, delivering advanced safety technology that transforms clinical practice.

SOURCE Flat Medical